Skip to main content

Table 2 MGMT promoter methylation, 1p/19q deletion, and clinical outcome of surgically resected pulmonary carcinoid and LCNEC

From: MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma

Patient

1p Del

19q Del

MGMTMet

Metastasis (ML)

DFS (mon)

OS (mon)

1

No

Yes

No

Yes (TV)

10

36

2

Yes

No

No

Yes (B)

29

29

3

No

Yes

Yes

No

22

22

4

No

No

No

No

41

41

5

Yes

No

Yes

Yes (B)

12

44

6

Yes

No

No

Yes (CV; DOD)

9

34

7

No

No

No

112

112

8

No

No

No

No

107

107

9

Yes

No

No

No

101

101

10

No

Yes

No

84

84

11

No

No

No

No

37

37

12

Yes

No

No

No

31

31

13

No

No

No

No

51

51

14

No

No

No

38

38

15

No

Yes

No

No

11

11

  1. LCNEC large-cell neuroendocrine carcinoma, Del deletion, Met methylation, ML metastatic lesions when the first metastasis occurred, B brain, TV thoracic vertebra, CV cervical vertebra, DOD dead of disease, DFS disease-free survival, OS overall survival